KLK1 and neoplasm: Mechanistically, loss of Klk1 promoted extracellular matrix (ECM) remodeling by upregulating Mmp2, Mmp9, Fap, decorin, and β‐catenin, thereby promoting epithelial‐mesenchymal transition and tumor progression.